Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge rates HUMA Bearish with a Setup Score of 18, net conviction 26, actionability 13. How the Setup Score works →
| Total Setup Score | 18 |
|---|---|
| Directional Bias | Bearish |
| Net Conviction | 26 |
| Actionability | 13 (in range) |
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign… Read full Trend Edge analysis →
| Current Price | $0.67 |
|---|---|
| Market Cap | $172M |
| Float | 196.1M |
| Shares Outstanding | 269.6M |
| P/E (Forward) | 35.84 |
| Price/Sales (TTM) | 85.41 |
| vs. Analyst Target | +206.0% to analyst PT |
| Operating Margin (TTM) | -5704.04% |
| Revenue (TTM) | $2.0M |
| Dividend Rate | None |
| Analyst Target Price | $2.05 (7 analysts) |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | $1.5M | -$66.5M | -$52.6M | -$56.2M |
| 2021 | $1.3M | -$26.5M | -$60.1M | -$13.9M |
| 2022 | $1.6M | -$12.0M | -$6.7M | $2.4M |
| 2023 | N/A | -$111M | -$76.5M | -$96.5M |
| 2024 | N/A | -$149M | -$7.2M | -$132M |
| 2025 | $2.0M | -$40.8M | -$15.0M | -$22.2M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Jun 2025 | $301,000 | -$37.7M |
| Sep 2025 | $753,000 | -$17.5M |
| Dec 2025 | $467,000 | -$24.8M |
| Mar 2026 | $495,000 | -$17.6M |
| Insider Ownership | 7.5% |
|---|---|
| Institutional Ownership | 22.3% |
| Short Float | 16.1% |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $0.87 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $1.00 | Medium-term trend |
| Weekly | 80-Week SMA | $1.67 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $3.04 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $1.03 | Near-term monthly trend |
| Monthly | 20-Month SMA | $1.85 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $3.04 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $1.30 | resistance | 2.45x | 1 months ago |
| $1.30 | resistance | 1.04x | 6 months ago |
| $2.20 | resistance | 1.39x | 11 months ago |
| $3.40 | resistance | 1.25x | 15 months ago |
| $9.50 | resistance | 1.76x | 22 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | 1.35% | 0.15% | 50.00% | 16.44% | -4.76% |
| 1 Day | 2.10% | 1.70% | 54.55% | 23.55% | -13.11% |
| 1 Week | 0.98% | -1.23% | 40.91% | 54.92% | -39.27% |
| 2 Weeks | 6.62% | 3.35% | 68.18% | 96.72% | -56.19% |
| 1 Month | 5.33% | 2.46% | 54.55% | 118.85% | -58.61% |
Next earnings: August 10, 2026 (10 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
| Day | Avg Return | Win Rate | Samples |
|---|---|---|---|
| Monday | 0.20% | 44.7% | 264 |
| Tuesday | -0.15% | 45.4% | 293 |
| Wednesday | 0.10% | 47.3% | 292 |
| Thursday | -0.25% | 40.0% | 285 |
| Friday | 0.04% | 47.7% | 283 |
Institutional holder breakdown coming soon.
Total institutional ownership: 22.3%
Total insider ownership: 7.5%
Founder-led management: Laura Niklason (Founder, President, Chief Executive Officer)
| Total Filings | 6 |
|---|---|
| Net Value | -$3.8M |
| Net Shares Change | -4,506,046 |
| % of Float | -2.3% |
| C-Suite Filings | 3 |
| Clusters Detected | 1 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Niklason Laura E | President, CEO and Director | -$3.7M | 1 | 1 sell |
| Dougan Brady W | -$3.7M | 1 | 1 sell | |
| Sebelius Kathleen | +$49,999.84 | 1 | 1 buy | |
| Sander Dale A. | CFO and Chief Corp. Dev. Off | -$41,146.873 | 1 | N/A |
| Parikh Shamik J | Chief Medical Officer | -$41,146.873 | 1 | N/A |
| Constantino Michael T. | +$9,839.5 | 1 | 1 buy |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2026-05-20 – 2026-05-20 | 4 | 4 | -$22,454.406 | 2 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-05-20 | Sebelius Kathleen | +$49,999.84 | Transaction at $0.88, now -23.9% | |
| 2026-05-20 | Constantino Michael T. | +$9,839.5 | Transaction at $0.89, now -25.1% | |
| 2025-08-20 | Niklason Laura E | President, CEO and Director | -$3.7M | Transaction at $1.67, now -59.8% |
| 2026-05-20 | Sander Dale A. | CFO and Chief Corp. Dev. Off | -$41,146.873 | Transaction at $0.90, now -25.3% |
| 2026-05-20 | Parikh Shamik J | Chief Medical Officer | -$41,146.873 | Transaction at $0.90, now -25.3% |
| 2025-08-20 | Dougan Brady W | -$3.7M | Transaction at $1.67, now -59.8% |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Humacyte Inc (HUMA) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for HUMA on Trend Edge →